Combating Antibiotic Resistance and the Discovery and Development of Novel Therapeutics for Tuberculosis Control

Edited by:

Christina Boucher, PhD, University of Florida, United States

Submission Status: Open | Submission Deadline: 25 July 2025

Mycobacterium tuberculosis, 3D illustration Mycobacteria is calling for submissions to our Collection on Combating Antibiotic Resistance and the Discovery and Development of Novel Therapeutics for Tuberculosis Control. This Collection invites original research articles, reviews and case studies, addressing the critical issues surrounding antibiotic resistance in Mycobacterium tuberculosis (MTB) and the pursuit of novel therapeutic strategies.

Image credit: © [M] Dr_Microbe / Stock.adobe.com

New Content Item This Collection supports and amplifies research related to SDG 3: Good Health & Well-Being.

Submit to Collection

Meet the Guest Editor

Back to top

Christina Boucher, PhD, University of Florida, United States

Christina Boucher photograph Dr Christina Boucher is an Associate Professor in the Department of Computer and Information Science and Engineering at the University of Florida. She has over 85 publications in bioinformatics, with over two dozen of them in succinct data structures and/or alignment. She oversees the development and maintenance of a number of software methods. Dr Boucher has built a team of collaborators in various biomedical sciences including microbiology, veterinarian medicine, epidemiology, public health and clinical sciences. She also actively works on increasing the diversity in bioinformatics education.

About the Collection

This special collection addresses the critical issues surrounding antibiotic resistance in Mycobacterium tuberculosis (MTB) and the pursuit of novel therapeutic strategies. It includes contributions that cover diverse aspects of tuberculosis (TB) control, such as genetic and molecular mechanisms underlying drug resistance, advances in diagnostics, the development of new antimicrobials, and alternative treatment approaches. By bringing together studies from clinical, molecular, and computational research, this collection provides a comprehensive perspective on current challenges and innovations in TB control.

The scope of this collection spans multiple facets of antibiotic resistance and TB treatment, targeting the growing threat posed by multi-drug resistant (MDR) and extensively drug-resistant (XDR) strains. It aims to advance our understanding of TB resistance and support the development of effective, sustainable therapeutic solutions for global TB control.

We invite researchers to contribute to this special Collection by submitting original research articles, reviews, and case studies. Topics of interest include but are not limited to:

•   Mechanisms of antibiotic resistance in Mycobacterium tuberculosis
•   Emerging trends in antimicrobial resistance patterns
•   Discovery of novel drug targets
•   Identification and optimization of new therapeutic compounds
•   Strategies for improving drug efficacy
•   The role of public health policies in managing resistant TB strains
•   Computational biology approaches in TB research
•   Biomarkers for TB diagnosis and treatment response
•   Environmental factors influencing TB transmission
•   Clinical management of drug-resistant tuberculosis

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of original research articles, reviews and case studies. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal.

Articles for this Collection should be submitted via our submission system, Snapp. Please, select the appropriate Collection title “Combating Antibiotic Resistance and the Discovery and Development of Novel Therapeutics for Tuberculosis Control" under the “Details” tab during the submission stage.

Articles will undergo the journal’s standard peer-review process and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer-review process. The peer-review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.